BioCentury | Mar 23, 2015
Finance

Expanding IP

...million) financing last year that coincided with the group's acquisition of fellow IP commercialization company Fusion IP plc...
BioCentury | Feb 14, 2014
Financial News

IP group raises $164 million

...BioCentury that the capital raising and acquisition of the 79.9% of fellow IP commercialization company Fusion IP plc...
BioCentury | Jan 27, 2014
Finance

Fusing IP estates

...Fusing IP estates The acquisition by IP Group plc (LSE:IPO) of fellow IP commercialization company Fusion IP plc...
...15 biotech or diagnostic investments, including genome sequencing play Oxford Nanopore Technologies Ltd. , while Fusion IP...
BioCentury | Jan 24, 2014
Financial News

IP Group to raise $123.3M

...fellow IP commercialization company Fusion IP plc (LSE:FIP) it does not already own in a stock deal. Fusion IP...
BioCentury | Apr 1, 2013
Financial News

Fusion IP proposes placing

Fusion IP plc (LSE:FIP), Sheffield, U.K. Business: Other, Finance Date announced: 3/25/13 Type: Placing To be raised: £20 million ($30.5 million) Shares: 36.4 million Price: 55p Shares outstanding prior: 73.1 million Investors: Institutional investors Note:...
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

...life sciences team at PricewaterhouseCoopers; and David Baynes, a co-founder of Celsis International plc and Fusion IP plc...
BioCentury | Mar 26, 2012
Financial News

Diurnal completes venture financing

...Cardiff, U.K. Business: Endocrine/Metabolic Date completed: 3/15/12 Type: Venture financing Raised: £335,000 ($530,205) Investors: Fusion IP...
BioCentury | Jan 2, 2012
Company News

Fusion IP, University of Sheffield deal

...University IP commercialization company Fusion IP partnered with an undisclosed pharmaceutical company to use the university's IP...
...Fusion owns the rights to all research generated from the university. Details were not disclosed. Fusion IP plc...
BioCentury | Jan 31, 2011
Emerging Company Profile

Medella: RAMPing up

...against receptor activity-modifying protein 3 (RAMP3) Disease focus: Cancer Clinical status: Discovery Founded: 2007 by Fusion IP...
...collaborators: University of Sheffield Corporate partners: None Number of employees: 1 Funds raised: Undisclosed Investors: Fusion IP...
BioCentury | Feb 15, 2010
Company News

Cardiff University gene/cell therapy news

Fusion IP, which commercializes the university's IP, spun out Progenteq Ltd. (Cardiff, U.K.), The newco will develop a cartilage replacement therapy for acute knee injuries based on the university's IP covering a defined population of...
Items per page:
1 - 10 of 32
BioCentury | Mar 23, 2015
Finance

Expanding IP

...million) financing last year that coincided with the group's acquisition of fellow IP commercialization company Fusion IP plc...
BioCentury | Feb 14, 2014
Financial News

IP group raises $164 million

...BioCentury that the capital raising and acquisition of the 79.9% of fellow IP commercialization company Fusion IP plc...
BioCentury | Jan 27, 2014
Finance

Fusing IP estates

...Fusing IP estates The acquisition by IP Group plc (LSE:IPO) of fellow IP commercialization company Fusion IP plc...
...15 biotech or diagnostic investments, including genome sequencing play Oxford Nanopore Technologies Ltd. , while Fusion IP...
BioCentury | Jan 24, 2014
Financial News

IP Group to raise $123.3M

...fellow IP commercialization company Fusion IP plc (LSE:FIP) it does not already own in a stock deal. Fusion IP...
BioCentury | Apr 1, 2013
Financial News

Fusion IP proposes placing

Fusion IP plc (LSE:FIP), Sheffield, U.K. Business: Other, Finance Date announced: 3/25/13 Type: Placing To be raised: £20 million ($30.5 million) Shares: 36.4 million Price: 55p Shares outstanding prior: 73.1 million Investors: Institutional investors Note:...
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

...life sciences team at PricewaterhouseCoopers; and David Baynes, a co-founder of Celsis International plc and Fusion IP plc...
BioCentury | Mar 26, 2012
Financial News

Diurnal completes venture financing

...Cardiff, U.K. Business: Endocrine/Metabolic Date completed: 3/15/12 Type: Venture financing Raised: £335,000 ($530,205) Investors: Fusion IP...
BioCentury | Jan 2, 2012
Company News

Fusion IP, University of Sheffield deal

...University IP commercialization company Fusion IP partnered with an undisclosed pharmaceutical company to use the university's IP...
...Fusion owns the rights to all research generated from the university. Details were not disclosed. Fusion IP plc...
BioCentury | Jan 31, 2011
Emerging Company Profile

Medella: RAMPing up

...against receptor activity-modifying protein 3 (RAMP3) Disease focus: Cancer Clinical status: Discovery Founded: 2007 by Fusion IP...
...collaborators: University of Sheffield Corporate partners: None Number of employees: 1 Funds raised: Undisclosed Investors: Fusion IP...
BioCentury | Feb 15, 2010
Company News

Cardiff University gene/cell therapy news

Fusion IP, which commercializes the university's IP, spun out Progenteq Ltd. (Cardiff, U.K.), The newco will develop a cartilage replacement therapy for acute knee injuries based on the university's IP covering a defined population of...
Items per page:
1 - 10 of 32